Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H31NO2.ClH |
Molecular Weight | 389.959 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC[C@@H](OC(C)=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=UXBPQRGCVJOTNT-TVNLMDKXSA-N
InChI=1S/C23H31NO2.ClH/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21;/h7-16,18,22H,6,17H2,1-5H3;1H/t18-,22-;/m1./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C23H31NO2 |
Molecular Weight | 353.4977 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12373424Curator's Comment: description was created based on several sources, including
https://en.wikipedia.org/wiki/Alphacetylmethadol
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12373424
Curator's Comment: description was created based on several sources, including
https://en.wikipedia.org/wiki/Alphacetylmethadol
Alphacetylmethadol (INN), aka α-acetylmethadol (AAM), is a synthetic opioid analgesic. Its levorotary enantiomer, levacetylmethadol, is an FDA-approved treatment for opioid addiction. Alphacetylmethadol is very similar in structure to methadone, a widely-prescribed treatment for opioid addiction. In the United States, it is a Schedule I controlled substance under the Controlled Substances Act with an ACSCN of 9603 and a 2013 annual manufacturing quota of 2 grams. Studies in rats indicate that alphacetylmethadol also evokes the heroin-like discriminative stimulus effects.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:59:32 GMT 2023
by
admin
on
Sat Dec 16 18:59:32 GMT 2023
|
Record UNII |
3SA3GLL5HG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3SA3GLL5HG
Created by
admin on Sat Dec 16 18:59:32 GMT 2023 , Edited by admin on Sat Dec 16 18:59:32 GMT 2023
|
PRIMARY | |||
|
201444
Created by
admin on Sat Dec 16 18:59:32 GMT 2023 , Edited by admin on Sat Dec 16 18:59:32 GMT 2023
|
PRIMARY | |||
|
53757-35-0
Created by
admin on Sat Dec 16 18:59:32 GMT 2023 , Edited by admin on Sat Dec 16 18:59:32 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|